Security Snapshot

BIO-TECHNE Corp - COMMON STOCK (TECH) Institutional Ownership

CUSIP: 09073M104

13F Institutional Holders and Ownership History from Q3 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

589

Shares (Excl. Options)

175,101,714

Price

$70.65

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.02%
Share change
-2,334,439
Value change
-$4,530,086
Number of holders
589
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
157,466,465
SEC-reported price per share
$71.63
Insider filing price
$71.63
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • TECH - BIO-TECHNE Corp - COMMON STOCK is tracked under CUSIP 09073M104.
  • 589 institutions reported positions in Q2 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 583 to 589 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $9,287,854,317 to $12,334,131,172.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 589 institutions filings for Q2 2026.

Open SEC evidence

Security key

09073M104

Latest holder period

Q2 2026

13F holders

589

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
TECH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 8.1% +62% $901,125,464 +$345,821,506 12,754,784 +62% FMR LLC 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC 7.4% $604,103,180 11,559,571 Vanguard Capital Management 31 Mar 2026
BlackRock, Inc. 7% $566,544,556 11,011,556 BlackRock, Inc. 30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% -57% $186,406,005 -$305,816,579 3,350,818 -62% T. Rowe Price Associates, Inc. 30 Sep 2025

As of 30 Jun 2026, 589 institutional investors reported holding 175,101,714 shares of BIO-TECHNE Corp - COMMON STOCK (TECH). This represents 111% of the company’s total 157,466,465 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
73%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.9% 14,025,816 +14% 0.01% $990,923,913
FMR LLC 8.1% 12,794,784 +62% 0.04% $903,951,465
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 10,218,558 +0.38% 0.02% $721,941,123
GOLDMAN SACHS GROUP INC 4.7% 7,343,324 +278% 0.05% $518,805,868
HBK INVESTMENTS L P 4.3% 6,825,000 5.6% $482,186,250
VANGUARD PORTFOLIO MANAGEMENT LLC 4.1% 6,506,360 +0.4% 0.02% $459,674,334
MORGAN STANLEY 4% 6,374,716 -25% 0.02% $450,373,948
STATE STREET CORP 3.8% 5,980,370 +1.9% 0.01% $422,513,141
GEODE CAPITAL MANAGEMENT, LLC 3.4% 5,351,464 +4.7% 0.02% $377,544,673
Invesco Ltd. 3.2% 4,986,424 +8.7% 0.03% $352,290,855
Ruane, Cunniff & Goldfarb L.P. 2.1% 3,348,841 -1.3% 3.7% $236,595,617
SNYDER CAPITAL MANAGEMENT L P 2% 3,163,816 +68% 3.9% $223,523,600
NEUBERGER BERMAN GROUP LLC 1.8% 2,844,692 -15% 0.13% $200,977,476
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.7% 2,746,462 -26% 0.07% $194,007,331
MAIRS & POWER INC 1.7% 2,700,698 -1.8% 1.8% $190,804,299
Capital Research Global Investors 1.7% 2,621,890 -18% 0.03% $185,236,529
UBS Group AG 1.6% 2,478,607 -19% 0.03% $175,113,585
DIMENSIONAL FUND ADVISORS LP 1.4% 2,253,512 +14% 0.03% $159,216,156
WHITEBOX ADVISORS LLC 1.3% 2,100,001 2.4% $148,365,071
Sumitomo Mitsui Trust Group, Inc. 1.3% 2,067,324 +0.63% 0.08% $146,056,441
ALLIANCEBERNSTEIN L.P. 1.3% 2,002,026 -9.5% 0.04% $104,625,879
JPMORGAN CHASE & CO 1.2% 1,862,805 +82% 0.01% $132,595,073
Amundi 1.2% 1,827,241 +2427% 0.03% $129,094,567
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1% 1,622,416 -0.86% 0.02% $114,623,691
MAVERICK CAPITAL LTD 0.98% 1,535,610 -68% 0.98% $108,490,847

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
48
Latest
Q2 2026
Rows shown
1-25 of 48
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 175,101,714 $12,334,131,172 -$4,530,086 $70.65 589
2026 Q1 177,411,067 $9,287,854,317 +$263,874,171 $52.26 583
2025 Q4 171,899,789 $10,111,517,379 +$653,769,239 $58.81 583
2025 Q3 158,850,861 $8,835,899,945 +$43,569,058 $55.63 569
2025 Q2 158,628,992 $8,162,083,726 -$121,661,613 $51.45 549
2025 Q1 160,482,754 $9,405,648,682 +$179,026,718 $58.63 570
2024 Q4 156,683,809 $11,287,230,171 +$66,773,071 $72.03 570
2024 Q3 154,600,456 $12,351,604,330 +$7,433,196 $79.93 556
2024 Q2 155,869,664 $11,167,617,679 -$177,733,977 $71.65 567
2024 Q1 158,523,717 $11,156,213,905 +$202,103,671 $70.39 546
2023 Q4 155,453,274 $11,990,770,023 +$252,157,462 $77.16 525
2023 Q3 152,193,816 $10,358,362,931 +$40,449,398 $68.07 522
2023 Q2 151,139,522 $12,331,718,195 +$212,796,041 $81.63 521
2023 Q1 148,715,946 $11,031,044,107 -$125,004,989 $74.19 542
2022 Q4 150,382,048 $12,465,020,754 +$9,251,047,940 $82.88 536
2022 Q3 38,142,242 $10,837,756,102 +$194,266,932 $284.00 520
2022 Q2 37,209,172 $12,897,621,890 -$179,595,754 $346.64 534
2022 Q1 37,711,486 $16,331,488,594 +$324,651,170 $433.04 546
2021 Q4 36,855,059 $19,055,177,448 -$21,586,911 $517.34 560
2021 Q3 36,736,696 $17,797,604,388 +$72,229,932 $484.57 556
2021 Q2 36,589,162 $16,468,259,256 +$203,566,288 $450.26 504
2021 Q1 36,496,866 $13,940,028,921 +$172,769,577 $381.93 460
2020 Q4 36,189,306 $11,493,926,712 -$16,778,721 $317.55 426
2020 Q3 36,254,970 $8,982,485,029 -$42,929,390 $247.73 409
2020 Q2 36,379,136 $9,604,991,764 -$81,539,071 $264.07 384
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .